Insiders · NDRA

NDRA insider transactions

ENDRA Life Sciences Inc. (NDRA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NDRA

• 96d
  Chief Executive Officer Tokman Alexander Y was granted 26,921 shares, increasing direct ownership by 36% to 101,926 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 96d
  Chief Financial Officer Jacroux Richard was granted 13,461 shares, increasing direct ownership by 67% to 33,461 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 136d
  Director Digiandomenico Anthony was granted 60,324 shares, increasing direct ownership by 79% to 136,589 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 136d
  Director Harsh Michael was granted 60,324 shares, increasing direct ownership by 1,120% to 65,710 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 136d
  Chief Financial Officer Jacroux Richard was granted 20,000 shares (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 136d
  Director Basenese Lou was granted 60,324 shares, increasing direct ownership by 1,120% to 65,709 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 136d
  Chief Executive Officer Tokman Alexander Y was granted 75,000 shares, increasing direct ownership by 1,500,000% to 75,005 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 236d
  Director Digiandomenico Anthony was granted 70,822 shares, increasing direct ownership by 1,301% to 76,265 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 342d
  Director Basenese Lou was granted 5,384 shares, increasing direct ownership by 538,400% to 5,385 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 342d
  Director Harsh Michael was granted 5,384 shares, increasing direct ownership by 269,200% to 5,386 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 342d
  Director Digiandomenico Anthony was granted 5,384 shares, increasing direct ownership by 9,125% to 5,443 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 641d
  Amendment: Market maker/broker-dealer Ubs Group Ag bought 0 shares (SEC Form 4)

  4/A - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 641d
  Amendment: New insider Ubs Group Ag claimed ownership of 146,012 shares (SEC Form 3)

  3/A - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 648d
  Large owner Ubs Group Ag bought $2,052 worth of shares (3,715 units at $0.55) (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 648d
  New insider Ubs Group Ag claimed ownership of 146,012 shares (SEC Form 3)

  3 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 662d
  SEC Form 3 filed by new insider Jacroux Richard

  3 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 836d
  SEC Form 4 filed by Harsh Michael

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 836d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 836d
  SEC Form 4 filed by Basenese Lou

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 836d
  SEC Form 4 filed by Tokman Alexander Y

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1113d
  SEC Form 4 filed by Thornton Michael Milos

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1132d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1223d
  SEC Form 4 filed by Basenese Lou

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1223d
  SEC Form 4 filed by Tokman Alexander Y

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1223d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1223d
  SEC Form 4 filed by Pestrikova Irina

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1223d
  SEC Form 4 filed by Harsh Michael

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1223d
  SEC Form 4 filed by Michelon Francois Roger

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1223d
  SEC Form 4 filed by Thornton Michael Milos

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1273d
  SEC Form 4: Thornton Michael Milos bought $5,100 worth of shares (1,500 units at $3.40), increasing direct ownership by 9% to 19,139 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1288d
  SEC Form 4: Tokman Alexander Y bought $1,700 worth of shares (10,000 units at $0.17), increasing direct ownership by 7% to 162,857 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1384d
  SEC Form 4: Thornton Michael Milos bought $5,400 worth of shares (20,000 units at $0.27), increasing direct ownership by 6% to 352,775 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1384d
  SEC Form 4: Tokman Alexander Y bought $5,200 worth of shares (20,000 units at $0.26), increasing direct ownership by 15% to 152,857 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1469d
  SEC Form 4: Thornton Michael Milos bought $5,250 worth of shares (25,000 units at $0.21), increasing direct ownership by 8% to 332,775 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1477d
  SEC Form 4: Thornton Michael Milos bought $5,500 worth of shares (25,000 units at $0.22), increasing direct ownership by 9% to 307,775 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1481d
  SEC Form 4: Michelon Francois Roger bought $969 worth of shares (5,100 units at $0.19), increasing direct ownership by 6% to 97,191 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1483d
  SEC Form 4: Tokman Alexander Y bought $19,630 worth of shares (100,000 units at $0.20), increasing direct ownership by 304% to 132,857 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1531d
  SEC Form 4 filed by Maloberti Renaud Bertrand

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1531d
  SEC Form 4 filed by Thornton Michael Milos

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1531d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1531d
  SEC Form 4 filed by Tokman Alexander Y

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1531d
  SEC Form 4 filed by Pestrikova Irina

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1531d
  SEC Form 4 filed by Harsh Michael

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1531d
  SEC Form 4 filed by Michelon Francois Roger

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1531d
  SEC Form 4 filed by Basenese Lou

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1616d
  SEC Form 4 filed by Tokman Alexander Y

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1616d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1616d
  SEC Form 4 filed by Harsh Michael

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1616d
  SEC Form 4 filed by Basenese Lou

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1720d
  SEC Form 4: Thornton Michael Milos was granted 22,815 units of Common Stock, increasing direct ownership by 8% to 316,525 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1746d
  SEC Form 4: Basenese Lou sold $91,600 worth of Common Stock (50,000 units at $1.83), decreasing direct ownership by 50% to 49,068 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1812d
  SEC Form 4 filed by Pestrikova Irina

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1812d
  SEC Form 3 filed by Pestrikova Irina

  3 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1865d
  SEC Form 4: Thornton Michael Milos was granted 22,815 units of Common Stock, increasing direct ownership by 8% to 316,525 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1888d
  SEC Form 4 filed by Y Alexander Tokman

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1888d
  SEC Form 4 filed by Michael Harsh

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1888d
  SEC Form 4 filed by Anthony Digiandomenico

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1888d
  SEC Form 4 filed by Lou Basenese

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1888d
  SEC Form 4 filed by Bertrand Renaud Maloberti

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1888d
  SEC Form 4 filed by R. David Wells

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)